Bladder cancer: Restaging TUR reduces recurrence and progression risk. Article uri icon

Overview

abstract

  • Transurethral resection (TUR) is widely used to manage early-stage bladder cancer. A recent study has confirmed that a second, or restaging, TUR is associated with a lower risk of progression and cancer-related death. Restaging TUR is therefore recommended as a standard of care in patients with stage T1 bladder cancer.

publication date

  • December 1, 2010

Research

keywords

  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 78650092822

Digital Object Identifier (DOI)

  • 10.1038/nrurol.2010.189

PubMed ID

  • 21139639

Additional Document Info

volume

  • 7

issue

  • 12